MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Impulse control disorder following bilateral pallidothalamic tract focused ultrasound: a case report

    S. Farrand, P. Phal, K. Fernando, A. Evans, R. Blaze (Richmond, Australia)

    Objective: Description of a case of ICD following non-contemporaneous bilateral pallidothalamic focused ultrasound tractotomy. Background: Impulsive and compulsive behaviours in PD are hypothesized to largely…
  • 2022 International Congress

    Does needle size matter in botulinum toxin injection? A crossover randomised controlled trial of microneedle in patients with hemifacial spasm

    S. Maytharakcheep, R. Bhidayasiri, O. Phokaewvarangkul (bangkok, Thailand)

    Objective: The aim of this study was to compare the severity of  pain and bruises between a microneedle (34-G) and standard needle (30-G) in patients…
  • 2022 International Congress

    NIMHANS Neuropsychological Battery for Elderly in Parkinson’s disease patients: Validation and diagnosis using MDS PD-MCI task force criteria in Indian population

    R. Yadav, R. Botta, K. Kumar, BM. Kutty, A. Mahadevan, PK. Pal (Bengaluru, India)

    Objective: To validate NIMHANS Neuropsychological Battery for Elderly( NNB-E) and evaluate cognitive impairment in Parkinson's disease (PD) patients in comparison with healthy controls. Background: Cognitive…
  • 2022 International Congress

    Real-world evidence and feasibility of telemedicine for Parkinson’s disease

    G. Rigas, N. Kostikis, N. Tachos, E. Kontogiannis, E. Kostoulas, A. Bousis, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)

    Objective: This work aims to provide real-world evidence for the feasibility of telemedicine in Parkinson’s disease (PD). Adherence data presented pertain to patients paying out…
  • 2022 International Congress

    High-beta Oscillations Predict Outcome of Subthalamic Deep Brain Stimulation in Parkinson’s Disease

    P-L. Chen, Y-C. Chen, P-H. Tu, T-C. Liu, H-T. Wu, M-C. Yeap, C-H. Yeh, C-S. Lu, C-C. Chen (Taoyuan City, Taiwan)

    Objective: We evaluated whether low-β and high-β band activity recorded from the subthalamic nucleus (STN) region predicts efficacy of deep brain stimulation (DBS) in Parkinson's…
  • 2022 International Congress

    Whole exome sequencing identifies novel variants underlying Ataxia with Oculomotor Apraxia type 1 in Pakistani consanguineous families

    S. Saadi, E. Cali, S. Efthymiou, S. Khan, A. Khan, J. Alvi, T. Sultan, M. Tariq, N. Malik, M. Breza, H. Houlden, S. Group, S. Baig (Faisalabad, Pakistan)

    Objective: To investigate the underlying pathogenic variants in four consanguineous Pakistani families segregating Ataxia with Oculomotor Apraxia type 1 Background: Ataxia with Oculomotor Apraxia type 1…
  • 2022 International Congress

    Neural and cognitive correlates of the co-occurrence of apathy and Impulse Control Disorder in early Parkinson’s Disease

    G. Maggi, S. Costa, F. Loayza, G. Santangelo, I. Obeso (Caserta, Italy)

    Objective: The present study aims to explore the co-occurrence of impulse control disorder (ICD) and apathy and its neural correlates analyzing anatomical changes in gray…
  • 2022 International Congress

    Exenatide protects iPSC-derived dopaminergic neurons with A53T mutation through restoration of insulin signaling

    D. Athauda, J. Evans, A. Wernick, G. Virdi, M. Choi, K. D'Sa, Z. Shadman, N. Greig, T. Foltynie, S. Gandhi (London, United Kingdom)

    Objective: Here we sought to investigate mechanisms by which insulin resistance affects PD pathogenesis in-vitro, and whether restoration of insulin signaling, using GLP-1 agonist exenatide…
  • 2022 International Congress

    Overnight stimulation: a new rescue strategy for deep brain stimulation-induced bradykinesia in dystonia?

    N. Pozzi, T. Binder, F. Avantaggiato, I. Isaias, J. Volkmann, P. Capetian (Wuerzburg, Germany)

    Objective: We report the serendipity case of overnight stimulation for the management of stimulation-induced bradykinesia in two patients with generalized dystonia and clinically-effective pallidal deep…
  • 2022 International Congress

    The anti-alpha-synuclein antibody Lu AF82422 was safe and well tolerated in a FIH-SAD study in healthy subjects and patients with PD

    L. Buur, J. Wiedemann, F. Larsen, F. Ben Alaya-Fourati, P. Kallunki, D. Ditlevsen, M. Sørensen, D. Meulien (Valby, Denmark)

    Objective: Evaluation of safety, tolerability, pharmacokinetics (PK) and target engagement (TE) in healthy subjects (HS) and patients with Parkinson’s disease (PD) following single ascending doses…
  • « Previous Page
  • 1
  • …
  • 782
  • 783
  • 784
  • 785
  • 786
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley